Application of intravenous inhalation compound anesthesia with laryngeal mask in interventional treatment of children with congenital heart disease

Objective To discuss the effect and safety use of laryngeal mask anesthesia management in interventional treatment of congenital heart disease in children. Methods Elective procedures for 60 children with congenital heart disease,aged 2 ~ 6 years,ASAⅠ~ Ⅱ,were randomly assigned into two groups: endotracheal intubation group( Ⅰgroup) and laryngeal mask group( Ⅱgroup),30 cases in each group. Endotracheal intubation was set up following the use of fentanyl 1 μg·kg- 1,propofol 2. 5 mg·kg- 1and rocuronium 0. 6mg·kg- 1inⅠgroup; LMA was applied followed by fentanyl 1 μg·kg- 1,propofol 2. 5 mg·kg- 1and sevoflurane. Parameters MAP,HR and SPO2 were measured and analyzed statistically perioperatively. We observed and compared hemodynamic changes,intraoperative,postoperative adverse reactions,and recovery time,meanwhile observed the presence of cough,postoperative laryngeal edema and so on. Results There were no actual differences in operation time,the value of MAP,HR and SPO2 before induction and placement or removal of LMA and endotracheal tube in two groups. However the values of HR,MAP were significantly lower in groupⅡ than those in groupⅠ after the insertion and removal of endotracheal tube or LMA( P 0. 05). Postoperative respiratory complications in groupⅡ were fewer than those inⅠgroup( P 0. 05). Conclusions Application of LMA in interventional surgical anesthesia of children with congenital heart disease allows intraoperative hemodynamic stable and fewer respiratory complications; combined with propofol,sevoflurane and other drugs can provide rapid postoperative recovery,which is worth promoting.